Key Highlights
- CeQur's innovative approach to insulin delivery simplifies mealtime dosing for individuals on multiple daily injections.
- The FDA's recent 510(k) clearance of CeQur Simplicity for an extended 4-day wear duration highlights the company's commitment to advancing diabetes care.
- CeQur Simplicity's ability to replace up to twelve daily mealtime injections with a single wearable patch demonstrates its potential to significantly improve patient convenience and adherence.
- The company's focus on discreet and injection-free bolus dosing aligns with the growing trend towards minimally invasive medical devices.
- CeQur's headquarters in Horw, Switzerland, positions it at the forefront of European medical device innovation.
About CeQur
CeQur is a medical device company based in Horw, Switzerland, dedicated to simplifying mealtime insulin delivery for individuals on multiple daily injections. The company manufactures CeQur Simplicity, a wearable insulin delivery device that enables discreet, convenient, and injection-free bolus dosing. In June 2024, the company announced the FDA's recent 510(k) clearance of CeQur Simplicity for an extended wear duration from 3 to 4 days. One CeQur Simplicity 4-day wearable patch holds up to 200 units of rapid-acting insulin administered in two-unit increments and replaces, on average, twelve daily mealtime injections over four days.
Founded in 2008, CeQur employs 131 people and operates as a privately held company. The company's mission is to improve the quality of life for individuals managing diabetes by providing innovative and user-friendly insulin delivery solutions.
For more information, visit myceqursimplicity.com.
Why Contact CeQur?
B2B professionals should contact CeQur for innovative insulin delivery solutions that simplify mealtime dosing and improve patient convenience. The company's FDA-cleared wearable device offers a unique value proposition for healthcare providers and patients seeking advanced diabetes management options.
Who Should Contact CeQur for Business?
Sales teams selling medical devices, healthcare providers, and pharmaceutical companies should reach out to CeQur. Recruiters seeking roles in medical device innovation and development should also consider this company.
Categories
- Medical Devices
- Insulin Delivery
- Wearable Technology
- Diabetes Management
- FDA Clearance
- Injection-Free
- Bolus Dosing
- Patient Convenience
- Medical Innovation
- Horw, Switzerland
More Medical Devices Companies
Frequently Asked Questions
- What does CeQur do?
- CeQur develops and manufactures the CeQur Simplicity, a wearable 4-day insulin patch designed for subcutaneous bolus delivery of insulin to manage diabetes mellitus in adults.
- How many employees does CeQur have?
- CeQur has approximately 131 employees.
- Where is CeQur headquartered?
- Horw, Switzerland
- What industry is CeQur in?
- CeQur operates in Medical Devices, Diabetes Management, Wearable Technology.
- When was CeQur founded?
- CeQur was founded in 2008.
- Is CeQur still active?
- Yes, CeQur was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to CeQur?
- Research CeQur's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to CeQur?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with CeQur